AP

ADVANZ PHARMA

Verified Job Source

Partner of choice in specialty, hospital, and rare disease medicines

London, England

Pharmaceutical Manufacturing
501–1,000 people

About

Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia. Our Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network complement our global operations. ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, specialty generics & biosimilars, and originator brands. Our products and pipeline cover a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases. We can only achieve our ambition with the passion of our dedicated and highly qualified people, acting in line with our company values of entrepreneurship, speed, and integrity.

Open positions

Key Account Manager - Pharma

On-site

Develop and execute a strategic business plan for the Quebec territory to drive product adoption and improve patient access. Collaborate cross-functionally with medical, marketing, and market access teams to manage relationships with healthcare professionals and institutions.

Key Account Manager - Pharma

Remote · Canada

Develop and execute strategic business and account plans across Quebec to grow the specialty medicines portfolio, support oncology accounts, and prepare for a biosimilar launch. Build stakeholder partnerships, communicate approved product information, address treatment-access barriers, collaborate across functions, and provide market insights.